Business Standard

HIV vaccine in the works, but hard to predict timeline: Mark Feinberg

The CEO of the International AIDS Vaccine Initiative said India lacks effective tools against infectious diseases like ebola, zika, AIDS

Photo: Shutterstock
Premium

<b> Photo: Shutterstock <b>

Ankur Paliwal New Delhi
Research on Acquired Immune Deficiency Syndrome, or AIDS, has advanced tremendously since the disease was first reported in 1981. Anti-retroviral drugs have allowed people living with AIDS enjoy longer and healthier lives. However, the development of an HIV vaccine continues to be a formidable challenge for scientists. Mark Feinberg, president and CEO of the International AIDS Vaccine Initiative (IAVI), who was in India recently, spoke to Ankur Paliwal about challenges in developing a vaccine, recent breakthroughs, and a rising anti-vaccine movement. Edited excerpts:

Why is it so challenging to make an AIDS vaccine?   

Most of the available vaccines against

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in